##### Table of Contents

---



SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549



FORM 10-Q



| | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
| | ----------------------------------------------------------------------------------------



FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2005



COMMISSION FILE NUMBER 0-13251



MEDICAL ACTION INDUSTRIES INC.

(Exact name of Registrant as specified in its charter)



|                                                              |  |                                    
|------------------------------------------------------------- |  | -----------------------------------
|DELAWARE                                                      |  | 11-2421849                         
|(State or other Jurisdiction ofincorporation or organization) |  | (I.R.S. EmployerIdentification No.)



800 Prime Place,
Hauppauge, New York 11788

(Address of Principal Executive Offices)



Registrants telephone number, including area code:

(631) 231-4600



Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months and (2) has been
subject to such filing requirements for the past 90 days.



Yes  þ    No ̈



Indicate by check mark whether the registrant is an accelerated filer (as
defined in Rule 126-b of the Exchange Act).

Yes  þ    No ̈



Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.):

Yes ̈No  þ



Indicate the number of shares outstanding of each of the issuers classes of common stock, as of the latest practicable date. 10,458,232 shares of common stock as of November 8, 2005.



---



---

##### Table of Contents

Form 10-Q



CONTENTS



|          |  |                                                                                           |  |        
|--------- |  | ----------------------------------------------------------------------------------------- |  | -------
|          |  |                                                                                           |  | PageNo.
|PART I -  |  | FINANCIAL INFORMATION                                                                     |  |        
|          |  |                                                                                          
|Item 1.   |  | Condensed Financial Statements                                                            |  |        
|          |  |                                                                                          
|          |  | Balance Sheets at September 30, 2005 (Unaudited) and March 31, 2005                       |  | 3-4    
|          |  |                                                                                          
|          |  | Statements of Earnings for the Three Months ended September 30, 2005 and 2004 (Unaudited) |  | 5      
|          |  |                                                                                          
|          |  | Statements of Earnings for the Six Months ended September 30, 2005 and 2004 (Unaudited)   |  | 6      
|          |  |                                                                                          
|          |  | Statements of Cash Flows for the Six Months ended September 30, 2005 and 2004 (Unaudited) |  | 7      
|          |  |                                                                                          
|          |  | Notes to Financial Statements (Unaudited)                                                 |  | 8-12   
|          |  |                                                                                          
|Item 2.   |  | Managements Discussion and Analysis of Financial Condition and Results of Operations     |  | 13-21  
|          |  |                                                                                          
|Item 3.   |  | Quantitative and Qualitative Disclosures about Market Risk                                |  | 21     
|          |  |                                                                                          
|Item 4.   |  | Procedures and Controls                                                                   |  | 22     
|          |  |                                                                                          
|PART II - |  | OTHER INFORMATION                                                                         |  |        



2



---

##### Table of Contents

Item 1.

MEDICAL ACTION INDUSTRIES INC.

Balance Sheets

(dollars in thousands)



|                                                                                                                   |  |                   |        |               |   |       
|------------------------------------------------------------------------------------------------------------------ |  | ----------------- | ------ | ------------- | - | ------
|                                                                                                                   |  | September 30,2005 |        | March 31,2005
|                                                                                                                   |  | (Unaudited)       |        |              
|ASSETS                                                                                                             |  |                   |        |               |   |       
|CURRENT ASSETS:                                                                                                    |  |                   |        |               |   |       
|Cash                                                                                                               |  | $                 | 6,824  |               | $ | 549   
|Accounts receivable, less allowance for doubtful accounts of $403 at September 30, 2005 and $367 at March 31, 2005 |  |                   | 12,867 |               |   | 11,486
|Inventories, net                                                                                                   |  |                   | 18,013 |               |   | 19,095
|Prepaid expenses                                                                                                   |  |                   | 870    |               |   | 662   
|Deferred income taxes                                                                                              |  |                   | 294    |               |   | 294   
|Prepaid income taxes                                                                                               |  |                   |       |               |   | 263   
|Other current assets                                                                                               |  |                   | 225    |               |   | 251   
|                                                                                                                   |  |                   |        |               |   |       
|TOTAL CURRENT ASSETS:                                                                                              |  |                   | 39,093 |               |   | 32,600
|                                                                                                                   |  |                  
|Property, plant and equipment, net                                                                                 |  |                   | 12,563 |               |   | 12,946
|Goodwill                                                                                                           |  |                   | 37,085 |               |   | 37,085
|Trademarks                                                                                                         |  |                   | 666    |               |   | 666   
|Other intangible assets, net                                                                                       |  |                   | 1,810  |               |   | 1,944 
|Other assets                                                                                                       |  |                   | 936    |               |   | 639   
|                                                                                                                   |  |                   |        |               |   |       
|TOTAL ASSETS:                                                                                                      |  | $                 | 92,153 |               | $ | 85,880
|                                                                                                                   |  |                   |        |               |   |       



The accompanying notes
are an integral part of these financial statements.



3



---

##### Table of Contents

Item 1.



MEDICAL ACTION INDUSTRIES INC.

Balance Sheets

(dollars in thousands)



|                                                                                                                                                                   |  |                   |        |               |   |       
|------------------------------------------------------------------------------------------------------------------------------------------------------------------ |  | ----------------- | ------ | ------------- | - | ------
|                                                                                                                                                                   |  | September 30,2005 |        | March 31,2005
|                                                                                                                                                                   |  | (Unaudited)       |        |              
|LIABILITIES AND SHAREHOLDERS EQUITY                                                                                                                               |  |                   |        |               |   |       
|CURRENT LIABILITIES:                                                                                                                                               |  |                   |        |               |   |       
|Accounts payable                                                                                                                                                   |  | $                 | 5,093  |               | $ | 5,817 
|Accrued expenses, payroll and payroll taxes                                                                                                                        |  |                   | 2,924  |               |   | 3,737 
|Accrued income taxes                                                                                                                                               |  |                   | 461    |               |   |      
|Current portion of long-term debt                                                                                                                                  |  |                   | 360    |               |   | 360   
|                                                                                                                                                                   |  |                   |        |               |   |       
|TOTAL CURRENT LIABILITIES:                                                                                                                                         |  |                   | 8,838  |               |   | 9,914 
|Deferred income taxes                                                                                                                                              |  |                   | 4,095  |               |   | 4,095 
|Long-term debt, less current portion                                                                                                                               |  |                   | 2,620  |               |   | 2,800 
|                                                                                                                                                                   |  |                   |        |               |   |       
|TOTAL LIABILITIES:                                                                                                                                                 |  |                   | 15,553 |               |   | 16,809
|                                                                                                                                                                   |  |                  
|COMMITMENTS                                                                                                                                                        |  |                   |        |               |   |       
|                                                                                                                                                                   |  |                  
|SHAREHOLDERS EQUITY:                                                                                                                                              |  |                   |        |               |   |       
|Common stock 15,000,000 shares authorized, $.001 par value; issued and outstanding 10,457,032 shares at September 30, 2005 and 10,292,657
shares at March 31, 2005 |  |                   | 10     |               |   | 10    
|Additional paid-in capital, net                                                                                                                                    |  |                   | 20,077 |               |   | 17,997
|Retained earnings                                                                                                                                                  |  |                   | 56,513 |               |   | 51,064
|                                                                                                                                                                   |  |                   |        |               |   |       
|TOTAL SHAREHOLDERS EQUITY:                                                                                                                                        |  |                   | 76,600 |               |   | 69,071
|                                                                                                                                                                   |  |                   |        |               |   |       
|TOTAL LIABILITIES & SHAREHOLDERS EQUITY:                                                                                                                          |  | $                 | 92,153 |               | $ | 85,880
|                                                                                                                                                                   |  |                   |        |               |   |       



The accompanying notes
are an integral part of these financial statements.



4



---

##### Table of Contents

Item 1.



MEDICAL ACTION INDUSTRIES INC.

Statements of Earnings

(dollars in thousands except per share data)

(Unaudited)



|                                             |  |                                  |        |   |      |   |        |  
|-------------------------------------------- |  | -------------------------------- | ------ | - | ---- | - | ------ | -
|                                             |  | Three Months Ended September 30, |       
|                                             |  | 2005                             |        |   | 2004 |  
|Net sales                                    |  | $                                | 37,595 |   |      | $ | 35,146 |  
|Cost of sales                                |  |                                  | 27,778 |   |      |   | 26,126 |  
|                                             |  |                                  |        |   |      |   |        |  
|Gross profit                                 |  |                                  | 9,817  |   |      |   | 9,020  |  
|Selling, general and administrative expenses |  |                                  | 5,097  |   |      |   | 4,697  |  
|Interest expense                             |  |                                  | 10     |   |      |   | 78     |  
|Interest income                              |  |                                  | (18    | ) |      |   | (2     | )
|                                             |  |                                  |        |   |      |   |        |  
|Income before income taxes                   |  |                                  | 4,728  |   |      |   | 4,247  |  
|Income tax expense                           |  |                                  | 1,764  |   |      |   | 1,586  |  
|                                             |  |                                  |        |   |      |   |        |  
|Net income                                   |  | $                                | 2,964  |   |      | $ | 2,661  |  
|                                             |  |                                  |        |   |      |   |        |  
|Net income per share basic                   |  | $                                | .28    |   |      | $ | .26    |  
|                                             |  |                                  |        |   |      |   |        |  
|Net income per share diluted                 |  | $                                | .28    |   |      | $ | .26    |  
|                                             |  |                                  |        |   |      |   |        |  



The accompanying notes
are an integral part of these financial statements.



5



---

##### Table of Contents

Item 1.



MEDICAL ACTION INDUSTRIES INC.

Statements of Earnings

(dollars in thousands except per share data)

(Unaudited)



|                                             |  |                                |        |   |      |   |        |  
|-------------------------------------------- |  | ------------------------------ | ------ | - | ---- | - | ------ | -
|                                             |  | Six Months Ended September 30, |       
|                                             |  | 2005                           |        |   | 2004 |  
|Net sales                                    |  | $                              | 73,571 |   |      | $ | 68,467 |  
|Cost of sales                                |  |                                | 54,764 |   |      |   | 50,657 |  
|                                             |  |                                |        |   |      |   |        |  
|Gross profit                                 |  |                                | 18,807 |   |      |   | 17,810 |  
|Selling, general and administrative expenses |  |                                | 10,129 |   |      |   | 9,440  |  
|Interest expense                             |  |                                | 38     |   |      |   | 193    |  
|Interest income                              |  |                                | (20    | ) |      |   | (8     | )
|                                             |  |                                |        |   |      |   |        |  
|Income before income taxes                   |  |                                | 8,660  |   |      |   | 8,185  |  
|Income tax expense                           |  |                                | 3,211  |   |      |   | 3,055  |  
|                                             |  |                                |        |   |      |   |        |  
|Net income                                   |  | $                              | 5,449  |   |      | $ | 5,130  |  
|                                             |  |                                |        |   |      |   |        |  
|Net income per share basic                   |  | $                              | .53    |   |      | $ | .50    |  
|                                             |  |                                |        |   |      |   |        |  
|Net income per share diluted                 |  | $                              | .52    |   |      | $ | .49    |  
|                                             |  |                                |        |   |      |   |        |  



The accompanying notes
are an integral part of these financial statements.



6



---

##### Table of Contents

Item 1.



MEDICAL ACTION INDUSTRIES INC.

Statements of Cash Flows

(dollars in thousands)

(Unaudited)



|                                                                                  |  |                                |         |   |      |   |         |  
|--------------------------------------------------------------------------------- |  | ------------------------------ | ------- | - | ---- | - | ------- | -
|                                                                                  |  | Six Months Ended September 30, |        
|                                                                                  |  | 2005                           |         |   | 2004 |  
|OPERATING ACTIVITIES                                                              |  |                                |         |   |      |   |         |  
|Net income                                                                        |  | $                              | 5,449   |   |      | $ | 5,130   |  
|Adjustments to reconcile net income to net cash provided by operating activities: |  |                                |         |   |      |   |         |  
|Depreciation                                                                      |  |                                | 803     |   |      |   | 814     |  
|Amortization                                                                      |  |                                | 224     |   |      |   | 342     |  
|Provision for doubtful accounts                                                   |  |                                | 36      |   |      |   | 48      |  
|Provision for impairment of property, plant and equipment                         |  |                                |        |   |      |   | 75      |  
|Loss on sale of property and equipment                                            |  |                                |        |   |      |   | 36      |  
|Tax benefit from exercise of options                                              |  |                                | 533     |   |      |   | 145     |  
|Changes in operating assets and liabilities:                                      |  |                                |         |   |      |   |         |  
|Accounts receivable                                                               |  |                                | (1,417  | ) |      |   | (288    | )
|Inventories                                                                       |  |                                | 1,082   |   |      |   | 437     |  
|Prepaid expense and other current assets                                          |  |                                | (182    | ) |      |   | (139    | )
|Other assets                                                                      |  |                                | (387    | ) |      |   | (100    | )
|Accounts payable                                                                  |  |                                | (724    | ) |      |   | (957    | )
|Income taxes payable                                                              |  |                                | 724     |   |      |   | 837     |  
|Accrued expenses, payroll and payroll taxes                                       |  |                                | (813    | ) |      |   | 709     |  
|                                                                                  |  |                                |         |   |      |   |         |  
|NET CASH PROVIDED BY OPERATING ACTIVITIES                                         |  |                                | 5,328   |   |      |   | 7,089   |  
|                                                                                  |  |                                |         |   |      |   |         |  
|INVESTING ACTIVITIES                                                              |  |                                |         |   |      |   |         |  
|Purchase of property, plant and equipment                                         |  |                                | (420    | ) |      |   | (306    | )
|Proceeds from sale of property and equipment                                      |  |                                |        |   |      |   | 20      |  
|Repayment of loans to officers                                                    |  |                                |        |   |      |   | 428     |  
|                                                                                  |  |                                |         |   |      |   |         |  
|NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES                               |  |                                | (420    | ) |      |   | 142     |  
|                                                                                  |  |                                |         |   |      |   |         |  
|FINANCING ACTIVITIES                                                              |  |                                |         |   |      |   |         |  
|Proceeds from revolving line of credit and long term borrowings                   |  |                                | 11,875  |   |      |   | 15,700  |  
|Principal payments on revolving line of credit and long term debt                 |  |                                | (12,055 | ) |      |   | (23,715 | )
|Proceeds from exercise of employee stock options                                  |  |                                | 1,547   |   |      |   | 784     |  
|                                                                                  |  |                                |         |   |      |   |         |  
|NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES                               |  |                                | 1,367   |   |      |   | (7,231  | )
|                                                                                  |  |                                |         |   |      |   |         |  
|Increase in cash                                                                  |  |                                | 6,275   |   |      |   |        |  
|Cash at beginning of year                                                         |  |                                | 549     |   |      |   | 545     |  
|                                                                                  |  |                                |         |   |      |   |         |  
|Cash at end of period                                                             |  | $                              | 6,824   |   |      | $ | 545     |  
|                                                                                  |  |                                |         |   |      |   |         |  
|Supplemental Disclosures:                                                         |  |                                |         |   |      |   |         |  
|Interest paid                                                                     |  | $                              | 78      |   |      | $ | 330     |  
|Income taxes paid                                                                 |  | $                              | 1,952   |   |      | $ | 2,082   |  



The accompanying notes
are an integral part of these financial statements



7



---

##### Table of Contents

Item 1.



MEDICAL ACTION INDUSTRIES INC.

NOTES TO FINANCIAL STATEMENTS

(Unaudited)



Note 1. SIGNIFICANT ACCOUNTING POLICIES



BASIS OF PRESENTATION



The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (US GAAP) for interim financial information
and with the instructions to Form 10-Q for quarterly reports under section 13 or 15(d) of the Securities Exchange Act of 1934. Accordingly, they do not include all of the information and footnotes required by US GAAP for complete financial
statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the six (6) month period ended September 30, 2005
are not necessarily indicative of the results that may be expected for the year ended March 31, 2006. For further information, refer to the financial statements and footnotes thereto included in the Companys annual report for the year
ended March 31, 2005.



STOCK COMPENSATION



In accordance with the provisions of Statement of Financial Accounting Standards
(SFAS) No. 123, the Company has elected to apply Accounting Principles Board Opinion (APB) No. 25 and related interpretations in accounting for its employee and director stock-based awards. All employee and director
stock-based awards were granted with an exercise price equal to the fair market value of the Companys common stock on their date of grant.



8



---

##### Table of Contents

Item 1.



Note 1.(continued)



Therefore, under the provisions of APB 25, no compensation expense has been recognized with respect to such awards. If the Company had
elected to recognize compensation expense based on the fair value of the employee and director stock-based awards granted at grant date as prescribed by SFAS No. 123, net income and earnings per share would have been reduced to the pro forma
amounts indicated in the table below:



|                                                                                                                                             |  |                                              |       |                               |   |       |  |      |       |  |   |      
|-------------------------------------------------------------------------------------------------------------------------------------------- |  | -------------------------------------------- | ----- | ----------------------------- | - | ----- |  | ---- | ----- |  | - | -----
|                                                                                                                                             |  | Three Months EndedSeptember 30,              |       | Six Months EndedSeptember 30,
|                                                                                                                                             |  | 2005                                         |       | 2004                          |   | 2005  |  | 2004
|                                                                                                                                             |  | (dollars in thousands except per share data)
|Net income  as reported                                                                                                                     |  | $                                            | 2,964 |                               | $ | 2,661 |  | $    | 5,449 |  | $ | 5,130
|Deduct: Total stock-based employee compensation expense determined under fair value based method from all awards, net of related tax
effects |  |                                              | 217   |                               |   | 222   |  |      | 359   |  |   | 483  
|                                                                                                                                             |  |                                              |       |                               |   |       |  |      |       |  |   |      
|Net income  pro forma                                                                                                                       |  | $                                            | 2,747 |                               | $ | 2,439 |  | $    | 5,090 |  | $ | 4,647
|Earnings per share  as reported:                                                                                                            |  |                                              |       |                               |   |       |  |      |       |  |   |      
|Basic                                                                                                                                        |  | $                                            | .28   |                               | $ | .26   |  | $    | .53   |  | $ | .50  
|Diluted                                                                                                                                      |  | $                                            | .28   |                               | $ | .26   |  | $    | .52   |  | $ | .49  
|Earnings per share  pro forma                                                                                                               |  |                                              |       |                               |   |       |  |      |       |  |   |      
|Basic                                                                                                                                        |  | $                                            | .26   |                               | $ | .24   |  | $    | .49   |  | $ | .45  
|Diluted                                                                                                                                      |  | $                                            | .26   |                               | $ | .23   |  | $    | .49   |  | $ | .45  



Note 2. INVENTORIES



Inventories, which are stated at the lower of cost (first-in, first-out) or market,
consist of the following:



|                |  |                           |        |               |   |       
|--------------- |  | ------------------------- | ------ | ------------- | - | ------
|                |  | September 30,2005         |        | March 31,2005
|                |  | (Unaudited)               |        |              
|                |  | (in thousands of dollars)
|Finished Goods  |  | $                         | 11,088 |               | $ | 11,603
|Work in Process |  |                           | 159    |               |   |      
|Raw Materials   |  |                           | 6,766  |               |   | 7,492 
|                |  |                           |        |               |   |       
|Total           |  | $                         | 18,013 |               | $ | 19,095
|                |  |                           |        |               |   |       



On an ongoing basis, inventory
quantities on hand are viewed and an analysis of the provision for excess and obsolete inventory is performed based primarily on the Companys estimated sales forecast of product demand, which is based on sales history and anticipated future
demand. Such provision for excess and obsolete inventory approximated $243,000 and $227,000 at September 30, 2005 and March 31, 2005, respectively.



9



---

##### Table of Contents

Item 1.



Note 3. NET INCOME PER SHARE



Basic earnings per share is based on the weighted average number of common shares outstanding without consideration of potential common
shares. Diluted earnings per share is based on the weighted average number of common and potential common shares outstanding. The calculation takes into account the shares that may be issued upon exercise of stock options, reduced by the shares that
may be repurchased with the funds received from the exercise, based on the average prices during the periods. Excluded from the calculation of earnings per share are options and warrants to purchase 204,000 shares for the three (3) and six
(6) months ended September 30, 2005 and 137,500 and 20,000 shares respectively for the three (3) and six (6) months ended September 30, 2004, as their inclusion would not have been dilutive. The following table sets forth
the computation of basic and diluted earnings per share for the three (3) and six (6) months ended September 30, 2005 and for the three (3) and six (6) months ended September 30, 2004.



|                                                                              |  |                                              |            |                                |   |            |  |      |            |  |   |           
|----------------------------------------------------------------------------- |  | -------------------------------------------- | ---------- | ------------------------------ | - | ---------- |  | ---- | ---------- |  | - | ----------
|                                                                              |  | Three Months Ended September 30,             |            | Six Months Ended September 30,
|                                                                              |  | 2005                                         |            | 2004                           |   | 2005       |  | 2004
|                                                                              |  | (dollars in thousands except per share data)
|Numerator:                                                                    |  |                                              |            |                                |   |            |  |      |            |  |   |           
|Net income for basic and dilutive earnings per share                          |  | $                                            | 2,964      |                                | $ | 2,661      |  | $    | 5,449      |  | $ | 5,130     
|                                                                              |  |                                              |            |                                |   |            |  |      |            |  |   |           
|Denominator:                                                                  |  |                                              |            |                                |   |            |  |      |            |  |   |           
|Denominator for basic earnings per share - weighted average shares            |  |                                              | 10,435,228 |                                |   | 10,254,603 |  |      | 10,375,322 |  |   | 10,241,258
|                                                                              |  |                                              |            |                                |   |            |  |      |            |  |   |           
|Effect of dilutive securities:                                                |  |                                              |            |                                |   |            |  |      |            |  |   |           
|Employee and director stock options                                           |  |                                              | 141,290    |                                |   | 171,917    |  |      | 160,338    |  |   | 187,868   
|Warrants                                                                      |  |                                              |           |                                |   | 8,674      |  |      | 403        |  |   | 8,796     
|                                                                              |  |                                              |            |                                |   |            |  |      |            |  |   |           
|Dilutive potential common shares                                              |  |                                              | 141,290    |                                |   | 180,591    |  |      | 160,741    |  |   | 196,664   
|                                                                              |  |                                              |            |                                |   |            |  |      |            |  |   |           
|Denominator for diluted earnings per share - adjusted weighted average shares |  |                                              | 10,576,518 |                                |   | 10,435,194 |  |      | 10,536,063 |  |   | 10,437,922
|                                                                              |  |                                              |            |                                |   |            |  |      |            |  |   |           
|Basic earnings per share                                                      |  | $                                            | .28        |                                | $ | .26        |  | $    | .53        |  | $ | .50       
|                                                                              |  |                                              |            |                                |   |            |  |      |            |  |   |           
|Diluted earnings per share                                                    |  | $                                            | .28        |                                | $ | .26        |  | $    | .52        |  | $ | .49       
|                                                                              |  |                                              |            |                                |   |            |  |      |            |  |   |           



10



---

##### Table of Contents

|Item 1. | 
|------- | 



Note 4. SHAREHOLDERS EQUITY



For the three (3) and six (6) months ended September 30, 2005, 96,500 and 164,375 stock options were exercised by employees of the Company in accordance with the Companys 1989 Non-Qualified Stock Option Plan and the
1994 Stock Incentive Plan, respectively. The exercise price of the options exercised ranged from $3.00 per share to $13.97 per share for the three (3) months ended September 30, 2005 and $2.88 per share to $13.97 per share for the six
(6) months ended September 30, 2005.



The net cash proceeds from
these exercises were $1,028,000 and $1,547,000 for the three (3) and six (6) months ended September 30, 2005, respectively.



For the three (3) and six (6) months ended September 30, 2004, 10,500 and 61,500 stock options were exercised by employees of the Company in accordance
with the Companys 1989 Non-Qualified Stock Option Plan and the 1994 Stock Incentive Plan, respectively. The exercise price of the options exercised ranged from $12.75 per share to $13.30 per share for the three (3) months ended
September 30, 2004 and $3.00 per share to $13.30 per share for the six (6) months ended September 30, 2004.



The net cash proceeds from these exercises were $139,000 and $784,000 for the three (3) and six (6) months ended September 30, 2004, respectively.



Note  5. IMPACT OF RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS



In November 2004, the Financial Accounting Standards Board
(FASB) issued SFAS No. 151, Inventory Costs (SFAS 151). SFAS 151 amends the guidance in Chapter 4 of Accounting Research Bulletin No. 43, Inventory Pricing to clarify the accounting for
amounts of idle facility expense, freight, handling costs and wasted material. SFAS 151 requires that these types of items be recognized as current period charges as they occur. The provisions of SFAS 151 are effective for inventory costs incurred
during fiscal years beginning after June 15, 2005. The adoption of this new accounting pronouncement is not expected to have a material impact on the Companys financial position, results of operations or cash flows.



In December 2004, the FASB issued SFAS No. 123(R), Accounting for Stock-Based
Compensation (SFAS 123(R)). SFAS 123(R) establishes standards for the accounting of transactions in which an entity exchanges its equity instruments for goods or services. This Statement focuses primarily on accounting for
transactions in which an entity obtains employee services in share-based payment transactions. SFAS 123(R) requires that the fair value of such equity instruments be recognized as expense in the historical financial statements as services are
performed. Prior to SFAS 123(R), only certain pro-forma disclosures of fair value were required. SFAS 123(R) shall be effective for the Company as of the beginning of the first interim reporting period for the fiscal year ended March 31, 2007.
The Company is currently evaluating the financial statement impact of the adoption of SFAS 123(R).



11



---

##### Table of Contents

|Item 1. | 
|------- | 



In December 2004, the FASB issued FASB Staff Position No. 109-1 (FSP 109-1), Application of SFAS No. 109, Accounting for Income Taxes, to the Tax Deduction on Qualified
Production Activities Provided by the American Jobs Creation Act of 2004. It is effective immediately. FSP 109-1 states that the tax deduction of qualified domestic production activities, which is provided by the American Jobs Creation Act of
2004, will be treated as a special deduction as described in SFAS No. 109. Consequently, the impact of the deduction, which is effective January 1, 2005, will be reported in the period in which the deduction is claimed on the
Companys income tax returns. To date, FSP 109-1 has not had a material effect on the Companys financial statements.



Note 6. OTHER MATTERS



The Company is a party to lawsuits arising out of the conduct of its ordinary course of business, including those related to product liability and the sale and distribution of its products, which management believes
are covered by insurance. While the results of such lawsuits cannot be predicted with certainty, management does not expect that the ultimate liabilities, if any, will have a material adverse effect on the financial position or results of operations
of the Company.



12



---

##### Table of Contents

|Item 2. | 
|------- | 



MANAGEMENTS DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS



Forward-Looking Statement



This report on Form 10-Q contains forward-looking statements as defined by the Private
Securities Litigation Reform Act of 1995. Forward-looking statements include plans and objectives of management for future operations, including plans and objectives relating to the future economic performance and financial results of the Company.
The forward-looking statements relate to (i) the expansion of the Companys market share, (ii) the Companys growth into new markets, (iii) the development of new products and product lines to appeal to the needs of the
Companys customers, and (iv) the retention of the Companys earnings for use in the operation and expansion of the Companys business.



Important factors and risks that could cause actual results to differ materially from those referred to in the forward-looking statements include, but are not limited to,
the effect of economic and market conditions, the impact of the consolidation throughout the healthcare supply chain, the impact of healthcare reform, opportunities for acquisitions and the Companys ability to effectively integrate acquired
companies, the ability of the Company to maintain its gross profit margins, the ability to obtain additional financing to expand the Companys business, the failure of the Company to successfully compete with the Companys competitors that
have greater financial resources, the loss of key management personnel or the inability of the Company to attract and retain qualified personnel, the impact of current or pending legislation and regulation, as well as the risks described from time
to time in the Companys filings with the Securities and Exchange Commission, which include this report on Form 10-Q and the Companys annual report on Form 10-K for the year ended March 31, 2005.



The forward-looking statements are based on current expectations and involve a number of
known and unknown risks and uncertainties that could cause the actual results, performance and/or achievements of the Company to differ materially from any future results, performance or achievements, express or implied, by the forward-looking
statements. Readers are cautioned not to place undue reliance on these forward-looking statements, and that in light of the significant uncertainties inherent in forward-looking statements, the inclusion of such statements should not be regarded as
a representation by the Company or any other person that the objectives or plans of the Company will be achieved.



13



---

##### Table of Contents

Item 2.



Six Months ended September 30, 2005 compared to Six Months ended September 30, 2004



Overview



The following table sets forth certain operational data for the periods indicated:



|                                             |  |                                |        |      |   |       
|-------------------------------------------- |  | ------------------------------ | ------ | ---- | - | ------
|                                             |  | Six months ended September 30,
|                                             |  | 2005                           |        | 2004
|                                             |  | (dollars in thousands)        
|Net sales                                    |  | $                              | 73,571 |      | $ | 68,467
|Gross profit                                 |  | $                              | 18,807 |      | $ | 17,810
|Selling, general and administrative expenses |  | $                              | 10,129 |      | $ | 9,440 
|Income before taxes                          |  | $                              | 8,660  |      | $ | 8,185 
|Net income                                   |  | $                              | 5,449  |      | $ | 5,130 



The following table sets forth certain
operational data as a percentage of net sales for the periods indicated:



|                                             |  |                                |   |  |      |  
|-------------------------------------------- |  | ------------------------------ | - |  | ---- | -
|                                             |  | Six months ended September 30, |  
|                                             |  | 2005                           |   |  | 2004 |  
|Net sales                                    |  | 100                            | % |  | 100  | %
|Gross profit                                 |  | 25.6                           | % |  | 26.0 | %
|Selling, general and administrative expenses |  | 13.8                           | % |  | 13.8 | %
|Income before taxes                          |  | 11.8                           | % |  | 12.0 | %
|Net income                                   |  | 7.4                            | % |  | 7.5  | %



The Company experienced its most
successful six months ever in terms of revenue. The Companys revenue increased by 7% to $73,571,000 and its net income increased by 6% to $5,449,000 for the six months ended September 30, 2005 over the six months ended September 30,
2004.



The Company has entered into agreements with nearly every major group
purchasing organization. These agreements, which expire at various times over the next several years, can be terminated typically on ninety (90) day advance notice and do not contain minimum purchase requirements. The Company, to date, has been
able to achieve significant compliance to their respective member hospitals. The termination or non-renewal of any of these agreements may result in the significant loss of business or lower average selling prices. In some cases, as these agreements
are renewed, the average selling prices could be materially lower.



Containment
systems for medical waste represents approximately 30% of the Companys revenue. The primary raw material utilized in the manufacture of this product line is plastic resin. During fiscal 2005, world events caused the cost of plastic resin to
increase and be extremely volatile. The volatility continued during the six months ended September 30, 2005 and the Company anticipates



14



---

##### Table of Contents

Item 2.



this to continue throughout fiscal 2006. In the past, the Company has been able, from time to time, to increase selling prices for certain of these products
to recover a portion of the increased cost. However, the Company is unable to give any assurance that it will be able to pass along future cost increases to its customers, if necessary.



Gross margin dollars increased primarily due to increased sales volume from greater domestic market penetration primarily of its minor
procedure kits and trays product line and its containment systems for medical waste product line. Gross margin as a percentage of sales decreased primarily due to lower average selling prices due to increased competition in the domestic market in
its operating room towel and laparotomy sponge product lines and increases in raw materials primarily in its containment system for medical waste product line.



The Companys financial condition was strengthened during the six months ended September 30, 2005 as a result of net cash provided by operating activities of
$5,328,000, which included $533,000 of tax benefit from exercise of stock options. The Company also received $1,547,000 in proceeds from the exercise of stock options. Those were the major factors in the Companys increase in cash of $6,275,000
and corresponding increase in the Companys current ratio of 4.4 at September 30, 2005 from 3.3 at March 31, 2005.



Results of Operations



The following table sets forth the major sales variance components for the six months ended September 30, 2005 versus September 30, 2004:



|                                              |  |                       |        |  
|--------------------------------------------- |  | --------------------- | ------ | -
|                                              |  | (dollars inthousands) |       
|Six months ended September 30, 2004 net sales |  | $                     | 68,467 |  
|New products                                  |  |                       | 289    |  
|Volume of existing products                   |  |                       | 5,629  |  
|Price/sales mix                               |  |                       | (814   | )
|                                              |  |                       |        |  
|Six months ended September 30, 2005 net sales |  | $                     | 73,571 |  
|                                              |  |                       |        |  



Net sales for the six months ended
September 30, 2005 increased $5,104,000 or 7% to $73,571,000 from $68,467,000 for the six months ended September 30, 2004. The increase in net sales of $5,104,000 was primarily attributed to a $2,994,000 or 16% increase in net sales of
containment systems for medical waste and a $3,397,000 or 19% increase in net sales of minor procedure kits and trays. Laparotomy sales dollars decreased $480,000 or 7%. Net sales of operating room towels increased $39,000 or .3%. The increase in
net sales was primarily attributed to $289,000 of net sales of new products, an increase of $5,629,000 due to increased sales volume of existing products and a decrease of $814,000 due to lower average selling prices and change in sales mix on
existing products.



Net sales of containment systems for medical waste and
minor procedure kits and trays increased primarily due to greater domestic market penetration and increased average selling prices. Unit sales of operating room towels increased 13% and average selling prices decreased 11%. Unit sales of laparotomy
sponges increased 3% and average selling prices decreased 4%. Management believes that the decrease in average selling prices of operating room towels and laparotomy



15



---

##### Table of Contents

Item 2.



sponges was primarily due to increased competition in the domestic market, which it believes will continue throughout fiscal 2006. Management believes that
the increase in net selling prices in containment systems was as a result of increased selling prices for certain of these products to recover a portion of increased resin costs.



Gross profit for the six months ended September 30, 2005 increased 6% to $18,807,000 from $17,810,000 for the six months ended
September 30, 2004. Gross profit as a percentage of net sales for the six months ended September 30, 2005 decreased to 25.6% from 26.0% for the six months ended September 30, 2004. The increase in gross profit dollars was primarily
attributable to the increase in net sales. The decrease in gross margin percentage was due primarily to lower average selling prices of certain product lines and increased purchase costs on certain raw materials.



The following table sets forth sales, cost of sales and selling, general and administrative
expense data for the periods indicated:



|                                             |  |                                |        |   |      |   |        |  
|-------------------------------------------- |  | ------------------------------ | ------ | - | ---- | - | ------ | -
|                                             |  | Six months ended September 30, |       
|                                             |  | 2005                           |        |   | 2004 |  
|                                             |  | (dollars in thousands)         |       
|Net sales                                    |  | $                              | 73,571 |   |      | $ | 68,467 |  
|Cost of sales                                |  |                                | 54,764 |   |      |   | 50,657 |  
|Gross profit                                 |  | $                              | 18,807 |   |      | $ | 17,810 |  
|Gross profit percentage                      |  |                                | 25.6   | % |      |   | 26.0   | %
|Selling, general and administrative expenses |  | $                              | 10,129 |   |      | $ | 9,440  |  
|As a percentage of net sales                 |  |                                | 13.8   | % |      |   | 13.8   | %



Selling, general and administrative
expenses for the six months ended September 30, 2005 increased 7% to $10,129,000 from $9,440,000 for the six months ended September 30, 2004. As a percentage of net sales, selling, general and administrative expenses remained consistent at
13.8% for the six months ended September 30, 2005 and 2004, respectively. Selling, general and administrative expenses increased primarily due to increased salary and related expenses as a result of the Companys current and anticipated
future growth, and increased salesmans commissions due to increased sales volume.



Interest expense for the six months ended September 30, 2005 decreased 80% to $38,000 from $193,000 for the six months ended September 30, 2004. The decrease in interest expense was attributable to a decrease in the average
principal loan balances during the six months ended September 30, 2005, as compared to the six months ended September 30, 2004. The decrease in principal loan balances outstanding was primarily attributable to net cash provided by
operating activities.



Net income for the six months ended September 30,
2005 increased to $5,449,000 from $5,130,000 for the six months ended September 30, 2004. The increase in net income is attributable to the aforementioned increase in net sales and gross profit and a decrease in interest expense, which were
partially offset by an increase in selling, general and administrative expenses.



16



---

##### Table of Contents

Item 2.



Three Months ended September 30, 2005 compared to Three Months ended September 30, 2004



Overview



The following table sets forth certain operational data for the periods indicated:



|                                             |  |                                  |        |      |   |       
|-------------------------------------------- |  | -------------------------------- | ------ | ---- | - | ------
|                                             |  | Three months ended September 30,
|                                             |  | 2005                             |        | 2004
|                                             |  | (dollars in thousands)          
|Net sales                                    |  | $                                | 37,595 |      | $ | 35,146
|Gross profit                                 |  | $                                | 9,817  |      | $ | 9,020 
|Selling, general and administrative expenses |  | $                                | 5,097  |      | $ | 4,697 
|Income before taxes                          |  | $                                | 4,728  |      | $ | 4,247 
|Net income                                   |  | $                                | 2,964  |      | $ | 2,661 



The following table sets forth certain
operational data as a percentage of net sales for the periods indicated:



|                                             |  |                                  |   |  |      |  
|-------------------------------------------- |  | -------------------------------- | - |  | ---- | -
|                                             |  | Three months ended September 30, |  
|                                             |  | 2005                             |   |  | 2004 |  
|Net sales                                    |  | 100                              | % |  | 100  | %
|Gross profit                                 |  | 26.1                             | % |  | 25.7 | %
|Selling, general and administrative expenses |  | 13.6                             | % |  | 13.4 | %
|Income before taxes                          |  | 12.6                             | % |  | 12.1 | %
|Net income                                   |  | 7.9                              | % |  | 7.6  | %



The Company experienced its most
successful quarter ever in terms of revenue and profitability. The Companys revenue increased by 7% to $37,595,000 and its net income increased by 11% to $2,964,000 for the quarter ended September 30, 2005 over the quarter ended
September 30, 2004.



The Company has entered into agreements with nearly
every major group purchasing organization. These agreements, which expire at various times over the next several years, can be terminated typically on ninety (90) day advance notice and do not contain minimum purchase requirements. The Company,
to date, has been able to achieve significant compliance to their respective member hospitals. The termination or non-renewal of any of these agreements may result in the significant loss of business or lower average selling prices. In some cases,
as these agreements are renewed, the average selling prices could be materially lower.



Containment systems for medical waste represents approximately 30% of the Companys revenue. The primary raw material utilized in the manufacture of this product line is plastic resin. During fiscal 2005, world events caused the cost
of plastic resin to increase and be extremely volatile. The volatility continued during the three months ended September 30, 2005 and the Company anticipates this to continue throughout fiscal 2006. In the past, the Company has been able, from



17



---

##### Table of Contents

Item 2.



time to time, to increase selling prices for certain of these products to recover a portion of the increased cost. However, the Company is unable to give any
assurance that it will be able to pass along future cost increases to its customers, if necessary.



Gross margin dollars increased primarily due to increased sales volume from greater domestic market penetration primarily of its minor procedure kits and trays product line and its containment systems for medical
waste product line. Gross margin as a percentage of sales increased primarily due to increased sales volume resulting in increased efficiencies and lower production costs in our manufacturing facilities.



Results of Operations



The following table sets forth the major sales variance components for the quarter ended
September 30, 2005 versus September 30, 2004:



|                                                |  |                       |        |  
|----------------------------------------------- |  | --------------------- | ------ | -
|                                                |  | (dollars inthousands) |       
|Three months ended September 30, 2004 net sales |  | $                     | 35,146 |  
|New products                                    |  |                       | 74     |  
|Volume of existing products                     |  |                       | 2,704  |  
|Price/sales mix                                 |  |                       | (329   | )
|                                                |  |                       |        |  
|Three months ended September 30, 2005 net sales |  | $                     | 37,595 |  
|                                                |  |                       |        |  



Net sales for the three months ended
September 30, 2005 increased $2,449,000 or 7% to $37,595,000 from $35,146,000 for the three months ended September 30, 2004. The increase in net sales of $2,449,000 was primarily attributed to a $1,482,000 or 15% increase in net sales of
containment systems for medical waste and a $1,907,000 or 20% increase in net sales of minor procedure kits and trays. Laparotomy sales dollars decreased $342,000 or 9%. Net sales of operating room towels increased $29,000 or 0.5%. The increase in
net sales was primarily attributed to $74,000 of net sales of new products, an increase of $2,704,000 due to increased sales volume of existing products and a decrease of $329,000 due to lower average selling prices and change in sales mix on
existing products.



Net sales of containment systems for medical waste and
minor procedure kits and trays increased primarily due to greater domestic market penetration and increased average selling prices. Unit sales of operating room towels increased 16% and average selling prices decreased 14%. Unit sales of laparotomy
sponges decreased 5% and average selling prices decreased 4%. Management believes that the decrease in average selling prices of operating room towels was primarily due to increased competition in the domestic market, which it believes will continue
throughout fiscal 2006. Management believes that the increase in net selling prices in containment systems was as a result of increased selling prices for certain of these products to recover a portion of increased resin costs.



Gross profit for the three months ended September 30, 2005 increased 9% to $9,817,000
from $9,020,000 for the three months ended September 30, 2004. Gross profit as a percentage of net sales for the three months ended September 30, 2005 increased to 26.1% from 25.7% for the three months ended September 30, 2004. The
increase in gross profit dollars was primarily attributable to the increase in net sales. The increase in gross margin percentage was due primarily to higher



18



---

##### Table of Contents

Item 2.



average selling prices of certain product lines somewhat offset by increased purchase costs on certain raw materials.



The following table sets forth sales, cost of sales and selling, general and administrative
expense data for the periods indicated:



|                                             |  |                                  |        |   |      |   |        |  
|-------------------------------------------- |  | -------------------------------- | ------ | - | ---- | - | ------ | -
|                                             |  | Three months ended September 30, |       
|                                             |  | 2005                             |        |   | 2004 |  
|                                             |  | (dollars in thousands)           |       
|Net sales                                    |  | $                                | 37,595 |   |      | $ | 35,146 |  
|Cost of sales                                |  |                                  | 27,778 |   |      |   | 26,126 |  
|Gross profit                                 |  | $                                | 9,817  |   |      | $ | 9,020  |  
|Gross profit percentage                      |  |                                  | 26.1   | % |      |   | 25.7   | %
|Selling, general and administrative expenses |  | $                                | 5,097  |   |      | $ | 4,697  |  
|As a percentage of net sales                 |  |                                  | 13.6   | % |      |   | 13.4   | %



Selling, general and administrative
expenses for the three months ended September 30, 2005 increased 9% to $5,097,000 from $4,697,000 for the three months ended September 30, 2004. As a percentage of net sales, selling, general and administrative expenses increased to 13.6%
for the three months ended September 30, 2005 from 13.4% for the three months ended September 30, 2004. Selling, general and administrative expenses increased primarily due to increased salary and related expenses as a result of the
Companys current and anticipated future growth, and increased salesmans commissions due to increased sales volume.



Interest expense for the three months ended September 30, 2005 decreased 87% to $10,000 from $78,000 for the three months ended September 30, 2004. The decrease
in interest expense was attributable to a decrease in the average principal loan balances during the three months ended September 30, 2005, as compared to the three months ended September 30, 2004. The decrease in principal loan balances
outstanding was primarily attributable to net cash provided by operating activities.



Net income for the three months ended September 30, 2005 increased to $2,964,000 from $2,661,000 for the three months ended September 30, 2004. The increase in net income is attributable to the aforementioned increase in net sales
and gross profit and a decrease in interest expense, which were partially offset by an increase in selling, general and administrative expenses.



19



---

##### Table of Contents

Item 2.



Liquidity and Capital Resources



The following table sets forth certain liquidity and capital resources data for the periods indicated:



|                         |  |                        |        |               |   |       
|------------------------ |  | ---------------------- | ------ | ------------- | - | ------
|                         |  | September 30,2005      |        | March 31,2005
|                         |  | (Unaudited)            |        |              
|                         |  | (dollars in thousands)
|Accounts Receivable, net |  | $                      | 12,867 |               | $ | 11,486
|Days Sales Outstanding   |  |                        | 29.8   |               |   | 28.2  
|Inventories, net         |  | $                      | 18,013 |               | $ | 19,095
|Inventory Turnover       |  |                        | 5.9    |               |   | 5.7   
|Current Assets           |  | $                      | 39,093 |               | $ | 32,600
|Working Capital          |  | $                      | 30,255 |               | $ | 22,686
|Current Ratio            |  |                        | 4.4    |               |   | 3.3   
|Total Borrowings         |  | $                      | 2,980  |               | $ | 3,160 
|Shareholders Equity     |  | $                      | 76,600 |               | $ | 69,071
|Debt to Equity Ratio     |  |                        | 0.04   |               |   | 0.05  



The Company had working capital of
$30,255,000 with a current ratio of 4.4 to 1 at September 30, 2005 as compared to working capital of $22,686,000 with a current ratio of 3.3 to 1 at March 31, 2005. Total borrowings outstanding were $2,980,000 with a debt to equity ratio
of .04 to 1 at September 30, 2005 as compared to $3,160,000 with a debt to equity ratio of .05 to 1 at March 31, 2005. The increase in cash at September 30, 2005 was primarily attributable to net cash provided by operating activities
of $5,328,000 and proceeds from exercise of employee stock options of $1,547,000.



The Company has financed its operations primarily through cash flow from operations and borrowings from its existing credit facilities. At September 30, 2005, the Company had a cash balance of $6,824,000 compared to $549,000 at
March 31, 2005.



The Companys operating activities provided cash of
$5,328,000 for the six months ended September 30, 2005 as compared to $7,089,000 provided for the six months ended September 30, 2004. Net cash provided for the six months ended September 30, 2005 consisted primarily of net income
from operations, depreciation and amortization, decreases in inventories and increases in income taxes payable. These sources of cash more than offset the increase in accounts receivable and decreases in accounts payable and accrued expenses,
payroll and payroll taxes. The decrease in accounts payable was due to purchasing strategies during the quarter ended March 31, 2005. The decreases in accrued expenses, payroll and payroll taxes, were primarily due to payment of fiscal 2005
commissions and bonuses. The increase in accounts receivable and days sales outstanding at September 30, 2005 was due to a higher concentration of sales at the end of the quarter when compared to the quarter ended March 31, 2005.



Investing activities used net cash of $420,000 and provided net cash of
$142,000 for the six months ended September 30, 2005 and September 30, 2004, respectively. The principal activity during the six months ended September 30, 2005 was purchases of property and equipment totaling $420,000.



20



---

##### Table of Contents

Item 2.



Financing activities provided cash of $1,367,000 for the six months ended September 30, 2005 compared to
$7,231,000 used for the six months ended September 30, 2004. Financing activities consisted primarily of cash proceeds from the exercise of stock options of $1,547,000.



As of March 31, 2005, the Company has entered into a material commitment to purchase and implement an enterprise resource planning
system. As of September 30, 2005 the Company has incurred $644,000 in costs related to this project which is included in other assets. Approximately $316,000 of these costs were incurred during the six months ended September 30, 2005. It
is anticipated that the total cost of the project will be approximately $2,200,000 and will be completed sometime during the first quarter of fiscal 2007.



The Company believes that the anticipated future cash flow from operations, coupled with its cash on hand and available funds under its revolving credit agreement, will
be sufficient to meet working capital requirements.



Item 3.



Quantitative and Qualitative
Disclosures about Market Risk



The Company is exposed to interest rate
change market risk with respect to its credit facility with a financial institution which is priced based on the alternate base rate of interest plus a spread of up to 3/4%, or at LIBOR rate plus a spread of up to 3 1/4%. The spread over the alternate base rate and LIBOR rates is determined based upon the Companys performance with regard to agreed-upon financial ratios. The Company decides at its sole discretion as to whether borrowings will
be at the alternate base rate or LIBOR. At September 30, 2005, there was no outstanding balance under the credit facility. Changes in the alternate base rates or LIBOR rates during fiscal 2006 will have a positive or negative effect on the
Companys interest expense.



In addition, the Company is
exposed to interest rate change market risk with respect to the proceeds received from the issuance and sale by the Buncombe County Industrial and Pollution Control Financing Authority Industrial Development Revenue Bonds. At September 30,
2005, $2,980,000 was outstanding for these Bonds. The Bonds bear interest at a variable rate determined weekly. During the six months ended September 30, 2005, the average interest rate on the Bonds approximated 2.7%. Each 1% fluctuation in
interest rates will increase or decrease the interest expense on the Bonds by approximately $30,000 on an annualized basis.



A significant portion of the Companys raw materials are purchased from China. All such purchases are transacted in U.S. dollars. The Companys financial
results, therefore, could be impacted by factors such as changes in foreign currency, exchange rates or weak economic conditions in foreign countries in the procurement of such raw materials. To date, sales of the Companys products outside the
United States have not been significant.



21



---

##### Table of Contents

Item 4.



Procedures and Controls



The Companys management, with the participation of the
Companys Chief Executive Officer and Principal Financial Officer, has evaluated the effectiveness of the Companys disclosure controls and procedures as of September 30, 2005. Based on this evaluation, the Companys Chief
Executive Officer and Principal Financial Officer concluded that the Companys disclosure controls and procedures are effective for gathering, analyzing and disclosing the information the Company is required to disclose in the reports it files
under the Securities Exchange Act of 1934, within the time periods specified in the SECs rules and forms. Such evaluation did not identify any change in the Companys internal control over financial reporting that occurred during the
six months ended September 30, 2005 that has materially affected, or is reasonably likely to materially affect, the Companys internal control over financial reporting.



22



---

##### Table of Contents



MEDICAL ACTION INDUSTRIES
INC.



PART II  OTHER INFORMATION



|Item 1. | Legal Proceedings
|------- | -----------------



There are no material legal proceedings against the Company or in which any of its property is subject.



|Item 2. | Changes in Securities
|------- | ---------------------



None



|Item 3. | Defaults upon Senior Securities
|------- | -------------------------------



None



|Item 4. | Submission of Matters to a Vote of Security Holders
|------- | ---------------------------------------------------



| | A. | The Registrant held its Annual Meeting of Stockholders on August 4, 2005.
| | -- | -------------------------------------------------------------------------



| | B. | Two Directors were elected at the Annual Meeting to serve until the Annual Meeting of Stockholders in 2008. The names of the Directors and votes cast in favor of their election and
votes withheld are as follows:
| | -- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|                    |  |           |  |              
|------------------- |  | --------- |  | -------------
|Name                |  | Votes for |  | VotesWithheld
|Dr. Philip F. Corso |  | 9,243,806 |  | 51,201       
|William W. Burke    |  | 9,243,806 |  | 51,201       



And, a nominee to
serve in Class I until the Annual Meeting of Stockholders in 2006:



|                 |  |           |  |       
|---------------- |  | --------- |  | ------
|Henry A. Berling |  | 9,243,806 |  | 51,201



| | C. | The stockholders also approved a proposal to ratify the appointment of Grant Thornton LLP as independent certified public accountants of the Company for the fiscal year ended
March 31, 2006; 9,182,026 shares voted in favor of the proposal, 49,929 shares voted against and 4,878 shares abstaining from voting.
| | -- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|Item 5. | Other Information
|------- | -----------------



None



---

##### Table of Contents

|Item 6. | Exhibits and Reports on Form 8-K
|------- | --------------------------------



| | (a) | Exhibits
| | --- | --------



31.1 and 31.2  Certifications pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002



32.1 and 32.2  Certifications pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002



| | (b) | Reports on Form 8-K
| | --- | -------------------



| | (i) | Current Report on Form 8-K dated August 2, 2005, covering Item 7.01  Results of Operations and Financial Condition and Item 9.01  Financial Statements and
Exhibits
| | --- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------



Pursuant to the requirements of the Securities Exchange
Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



---

##### Table of Contents

|                        |  |  |  |                                |  |                         |  |                                                                                              
|----------------------- |  |  |  | ------------------------------ |  | ----------------------- |  | ---------------------------------------------------------------------------------------------
|                        |  |  |  | MEDICAL ACTION INDUSTRIES INC.
|                        |  |  | 
|Dated: November 8, 2005 |  |  |  | By:                            |  | /s/    RICHARD G. SATIN
|                        |  |  |  |                                |  |                         |  | Richard G. Satin Principal Financial Officer Vice President of Operations and General Counsel